1 October 2019 in Annals of Plastic Surgery
Radiotherapy (RT) has become an indispensable part of oncologic treatment protocols for a range of malignancies. However, a serious adverse effect of RT is radiodermatitis; almost 95% of patients develop moderate to severe skin reactions following radiation treatment. In the acute setting, these can be erythema, desquamation, ulceration, and pain. Chronically, soft tissue atrophy, alopecia, and stiffness can be noted. Radiodermatitis can delay oncologic treatment protocols and significantly impair quality of life. There is currently a paucity of effective treatment options and prevention strategies for radiodermatitis. Importantly, recent preclinical and clinical studies have suggested that fat grafting may be of therapeutic benefit, reversing detrimental changes to soft tissue following RT. This review outlines the damaging effects of RT on the skin and soft tissue as well as discusses available treatment options for radiodermatitis. Emerging strategies to mitigate detrimental, chronic radiation-induced changes are also presented.
28 July 2014 in Proceedings of the National Academy of Sciences
Significance: Prevailing theory suggests that episodic memory encoding is subserved by early remodeling of hippocampal circuits, whereas remodeling of the neocortex occurs weeks to months later to promote long-term memory storage and recall. Herein, we show that episodic memory encoding elicits early remodeling of neocortical circuits in mouse brain. Specifically, memory encoding triggered a transcriptomic program in the medial prefrontal cortex (mPFC) that was accompanied by rapid structural and functional plasticity of local synaptic circuits. Using optogenetics to examine the real-time contribution of the mPFC to memory encoding, we found that activity of excitatory mPFC neurons is required for hippocampal activation and formation of long-term memory. These data have important implications for understanding memory processing in healthy and diseased brain states.
5 February 2018 in Current Pain and Headache Reports
1 September 2021 in Science Translational Medicine
JUN drives scarring by modifying the roles of fibroblast subpopulations, and JUN antagonism via CD36 may represent an antiscarring therapy.
21 June 2019 in Annals of Surgical Oncology